Cargando…

Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia

Neuroblastoma (NB) is an embryonal malignancy derived from the abnormal differentiation of the sympathetic nervous system. The Anaplastic Lymphoma Kinase (ALK) gene is frequently altered in NB, through copy number alterations and activating mutations, and represents a predisposition in NB-genesis wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivancos Stalin, Lucie, Gualandi, Marco, Schulte, Johannes Hubertus, Renella, Raffaele, Shakhova, Olga, Mühlethaler-Mottet, Annick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477091/
https://www.ncbi.nlm.nih.gov/pubmed/31058082
http://dx.doi.org/10.3389/fonc.2019.00275
_version_ 1783412997842010112
author Vivancos Stalin, Lucie
Gualandi, Marco
Schulte, Johannes Hubertus
Renella, Raffaele
Shakhova, Olga
Mühlethaler-Mottet, Annick
author_facet Vivancos Stalin, Lucie
Gualandi, Marco
Schulte, Johannes Hubertus
Renella, Raffaele
Shakhova, Olga
Mühlethaler-Mottet, Annick
author_sort Vivancos Stalin, Lucie
collection PubMed
description Neuroblastoma (NB) is an embryonal malignancy derived from the abnormal differentiation of the sympathetic nervous system. The Anaplastic Lymphoma Kinase (ALK) gene is frequently altered in NB, through copy number alterations and activating mutations, and represents a predisposition in NB-genesis when mutated. Our previously published data suggested that ALK activating mutations may impair the differentiation potential of neural crest (NC) progenitor cells. Here, we demonstrated that the expression of the endogenous ALK gene starts at E10.5 in the developing sympathetic ganglia (SG). To decipher the impact of deregulated ALK signaling during embryogenesis on the formation and differentiation of sympathetic neuroblasts, Sox10-Cre;LSL-ALK-F1174L embryos were produced to restrict the expression of the human ALK-F1174L transgene to migrating NC cells (NCCs). First, ALK-F1174L mediated an embryonic lethality at mid-gestation and an enlargement of SG with a disorganized architecture in Sox10-Cre;LSL-ALK-F1174L embryos at E10.5 and E11.5. Second, early sympathetic differentiation was severely impaired in Sox10-Cre;LSL-ALK-F1174L embryos. Indeed, their SG displayed a marked increase in the proportion of NCCs and a decrease of sympathetic neuroblasts at both embryonic stages. Third, neuronal and noradrenergic differentiations were blocked in Sox10-Cre;LSL-ALK-F1174L SG, as a reduced proportion of Phox2b(+) sympathoblasts expressed βIII-tubulin and almost none were Tyrosine Hydroxylase (TH) positive. Finally, at E10.5, ALK-F1174L mediated an important increase in the proliferation of Phox2b(+) progenitors, affecting the transient cell cycle exit observed in normal SG at this embryonic stage. Altogether, we report for the first time that the expression of the human ALK-F1174L mutation in NCCs during embryonic development profoundly disturbs early sympathetic progenitor differentiation, in addition to increasing their proliferation, both mechanisms being potential crucial events in NB oncogenesis.
format Online
Article
Text
id pubmed-6477091
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64770912019-05-03 Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia Vivancos Stalin, Lucie Gualandi, Marco Schulte, Johannes Hubertus Renella, Raffaele Shakhova, Olga Mühlethaler-Mottet, Annick Front Oncol Oncology Neuroblastoma (NB) is an embryonal malignancy derived from the abnormal differentiation of the sympathetic nervous system. The Anaplastic Lymphoma Kinase (ALK) gene is frequently altered in NB, through copy number alterations and activating mutations, and represents a predisposition in NB-genesis when mutated. Our previously published data suggested that ALK activating mutations may impair the differentiation potential of neural crest (NC) progenitor cells. Here, we demonstrated that the expression of the endogenous ALK gene starts at E10.5 in the developing sympathetic ganglia (SG). To decipher the impact of deregulated ALK signaling during embryogenesis on the formation and differentiation of sympathetic neuroblasts, Sox10-Cre;LSL-ALK-F1174L embryos were produced to restrict the expression of the human ALK-F1174L transgene to migrating NC cells (NCCs). First, ALK-F1174L mediated an embryonic lethality at mid-gestation and an enlargement of SG with a disorganized architecture in Sox10-Cre;LSL-ALK-F1174L embryos at E10.5 and E11.5. Second, early sympathetic differentiation was severely impaired in Sox10-Cre;LSL-ALK-F1174L embryos. Indeed, their SG displayed a marked increase in the proportion of NCCs and a decrease of sympathetic neuroblasts at both embryonic stages. Third, neuronal and noradrenergic differentiations were blocked in Sox10-Cre;LSL-ALK-F1174L SG, as a reduced proportion of Phox2b(+) sympathoblasts expressed βIII-tubulin and almost none were Tyrosine Hydroxylase (TH) positive. Finally, at E10.5, ALK-F1174L mediated an important increase in the proliferation of Phox2b(+) progenitors, affecting the transient cell cycle exit observed in normal SG at this embryonic stage. Altogether, we report for the first time that the expression of the human ALK-F1174L mutation in NCCs during embryonic development profoundly disturbs early sympathetic progenitor differentiation, in addition to increasing their proliferation, both mechanisms being potential crucial events in NB oncogenesis. Frontiers Media S.A. 2019-04-16 /pmc/articles/PMC6477091/ /pubmed/31058082 http://dx.doi.org/10.3389/fonc.2019.00275 Text en Copyright © 2019 Vivancos Stalin, Gualandi, Schulte, Renella, Shakhova and Mühlethaler-Mottet. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Vivancos Stalin, Lucie
Gualandi, Marco
Schulte, Johannes Hubertus
Renella, Raffaele
Shakhova, Olga
Mühlethaler-Mottet, Annick
Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
title Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
title_full Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
title_fullStr Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
title_full_unstemmed Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
title_short Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia
title_sort expression of the neuroblastoma-associated alk-f1174l activating mutation during embryogenesis impairs the differentiation of neural crest progenitors in sympathetic ganglia
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477091/
https://www.ncbi.nlm.nih.gov/pubmed/31058082
http://dx.doi.org/10.3389/fonc.2019.00275
work_keys_str_mv AT vivancosstalinlucie expressionoftheneuroblastomaassociatedalkf1174lactivatingmutationduringembryogenesisimpairsthedifferentiationofneuralcrestprogenitorsinsympatheticganglia
AT gualandimarco expressionoftheneuroblastomaassociatedalkf1174lactivatingmutationduringembryogenesisimpairsthedifferentiationofneuralcrestprogenitorsinsympatheticganglia
AT schultejohanneshubertus expressionoftheneuroblastomaassociatedalkf1174lactivatingmutationduringembryogenesisimpairsthedifferentiationofneuralcrestprogenitorsinsympatheticganglia
AT renellaraffaele expressionoftheneuroblastomaassociatedalkf1174lactivatingmutationduringembryogenesisimpairsthedifferentiationofneuralcrestprogenitorsinsympatheticganglia
AT shakhovaolga expressionoftheneuroblastomaassociatedalkf1174lactivatingmutationduringembryogenesisimpairsthedifferentiationofneuralcrestprogenitorsinsympatheticganglia
AT muhlethalermottetannick expressionoftheneuroblastomaassociatedalkf1174lactivatingmutationduringembryogenesisimpairsthedifferentiationofneuralcrestprogenitorsinsympatheticganglia